1. Home
  2. LEGN vs ADT Comparison

LEGN vs ADT Comparison

Compare LEGN & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • ADT
  • Stock Information
  • Founded
  • LEGN 2014
  • ADT 1874
  • Country
  • LEGN United States
  • ADT United States
  • Employees
  • LEGN N/A
  • ADT N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • ADT Diversified Commercial Services
  • Sector
  • LEGN Health Care
  • ADT Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • ADT Nasdaq
  • Market Cap
  • LEGN 6.7B
  • ADT 7.0B
  • IPO Year
  • LEGN 2020
  • ADT 2018
  • Fundamental
  • Price
  • LEGN $33.11
  • ADT $8.82
  • Analyst Decision
  • LEGN Strong Buy
  • ADT Buy
  • Analyst Count
  • LEGN 12
  • ADT 5
  • Target Price
  • LEGN $73.36
  • ADT $9.34
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • ADT 9.5M
  • Earning Date
  • LEGN 11-11-2025
  • ADT 10-23-2025
  • Dividend Yield
  • LEGN N/A
  • ADT 2.49%
  • EPS Growth
  • LEGN N/A
  • ADT N/A
  • EPS
  • LEGN N/A
  • ADT 0.68
  • Revenue
  • LEGN $796,838,000.00
  • ADT $5,058,741,000.00
  • Revenue This Year
  • LEGN $70.75
  • ADT $6.18
  • Revenue Next Year
  • LEGN $52.47
  • ADT $4.23
  • P/E Ratio
  • LEGN N/A
  • ADT $13.00
  • Revenue Growth
  • LEGN 74.75
  • ADT 6.58
  • 52 Week Low
  • LEGN $27.34
  • ADT $6.68
  • 52 Week High
  • LEGN $52.31
  • ADT $8.89
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 36.16
  • ADT 57.02
  • Support Level
  • LEGN $33.20
  • ADT $8.52
  • Resistance Level
  • LEGN $34.71
  • ADT $8.89
  • Average True Range (ATR)
  • LEGN 1.22
  • ADT 0.14
  • MACD
  • LEGN -0.09
  • ADT -0.00
  • Stochastic Oscillator
  • LEGN 10.96
  • ADT 81.99

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About ADT ADT Inc.

ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name. The company segments include Consumer and Small Business (CSB).

Share on Social Networks: